2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Ranzani OT, Hitchings MDT, de Melo RL, de França GVA, Fernandes CFR, Lind ML, Torres MSS, Tsuha DH, David LCS, Said RFC, Almiron M, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nature Communications 2022, 13: 5536. PMID: 36202800, PMCID: PMC9537178, DOI: 10.1038/s41467-022-33169-0.Peer-Reviewed Original ResearchMeSH KeywordsAdultBNT162 VaccineBrazilCase-Control StudiesCOVID-19COVID-19 VaccinesHumansVaccines, Inactivated
2021
Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
Croda J, Ranzani O. Booster doses for inactivated COVID-19 vaccines: if, when, and for whom. The Lancet Infectious Diseases 2021, 22: 430-432. PMID: 34890538, PMCID: PMC8651253, DOI: 10.1016/s1473-3099(21)00696-4.Peer-Reviewed Original Research